FDA Unveils First Phase of Transparency Initiative
The U.S. Food and Drug Administration today unveiled the first phase of its Transparency Initiative which is designed to explain agency operations, how it makes decisions, and the drug approval process. During an online presentation, the chair of the FDA s Transparency Task Force, Principal Deputy FDA Commissioner Joshua Sharfstein, described a Web-based curriculum called FDA Basics, aimed at helping the public better understand what the agency does. The curriculum is accessible via a link on the FDA Web site.